Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival.
about
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaInitial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancerComplement factor H autoantibodies are associated with early stage NSCLC.A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development.Molecular imaging in therapeutic efficacy assessment of targeted therapy for nonsmall cell lung cancerRadiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancer.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.Optimization of response classification criteria for patients with malignant pleural mesothelioma.Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settingsTumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.Molecular imaging and targeted therapies.Correlation of [18F]-2-fluoro-deoxy-D-glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung cancer.Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.Drugs for solid cancer: the productivity crisis prompts a rethink.Declines in serum CYFRA21-1 and carcinoembryonic antigen as predictors of chemotherapy response and survival in patients with advanced non-small cell lung cancerImpact of early tumor shrinkage on clinical outcome in wild-type-KRAS colorectal liver metastases treated with cetuximab.Radiomic features analysis in computed tomography images of lung nodule classification.CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours.
P2860
Q23760721-1A29CB74-A970-4E97-8926-3D9ADA66898CQ28303718-9D9C16D2-378C-4BD4-A768-ACA04B4E5EABQ33771180-B43958AB-A2CA-4348-82CF-4CEC732D5836Q33937882-BED4F9FE-2751-4604-BFAA-5F9876721CE9Q34134408-63601019-484B-4D81-BF9F-A254DE41FCE2Q34243500-9C58EE55-4215-4179-8919-9218E2A833C0Q34488635-655A1EE6-F80E-4ECA-88E0-CB1BB1303678Q34978457-9EED1486-5EEC-4EE5-85CF-20348F8C0C3BQ35876285-D92287BF-E3B8-4554-AD53-663E1005A4A7Q36276553-2B6E752E-950C-44CE-ACC7-800FC33F3460Q36322856-2E3D9244-D5E2-4630-A857-DAF7D68400DEQ36545344-11238347-9AA6-40A9-ACC9-58E13E653455Q36626050-1D45D7CF-C394-4832-84A7-6FC062A24363Q37021940-1B23962E-A43A-4991-B17C-030EBA6E1AD6Q37732704-0B74BE2C-1243-4668-A24C-DCA690C1858AQ37763664-8133FD96-EFC1-48F6-A340-57301E059B6DQ38853138-7A31BABF-47C1-416A-BD9F-C43167A71582Q41313977-2B9B5EB3-CE19-43EA-AD3B-49684716002EQ42013318-F0190633-542C-4A9D-AA92-E154142605F8Q42181722-60659CE5-F2C6-4111-8E4D-EB3E80CD8FECQ48041780-A8C0D4CA-B3B6-4910-A3F3-505E73F4B8E4Q51709008-A9B9A03F-3FD4-4E63-8CF1-0AA80ABAD946
P2860
Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early changes in tumor size in ...... o not correlate with survival.
@en
Early changes in tumor size in ...... o not correlate with survival.
@nl
type
label
Early changes in tumor size in ...... o not correlate with survival.
@en
Early changes in tumor size in ...... o not correlate with survival.
@nl
prefLabel
Early changes in tumor size in ...... o not correlate with survival.
@en
Early changes in tumor size in ...... o not correlate with survival.
@nl
P2093
P356
P1433
P1476
Early changes in tumor size in ...... o not correlate with survival.
@en
P2093
Edward F Patz
James E Herndon
Katherine R Birchard
P304
P356
10.1002/CNCR.24060
P407
P577
2009-02-01T00:00:00Z